Plasma-Based Metabolomics
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 238
Special Issue Editor
Interests: liver ischemia reperfusion injury; hepatocellular carcinoma; kidney transplant outcomes; health disparities in organ transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Successfully achieving the goal of effective, targeted, individualized therapeutic strategies in the clinical care of patients requires biologic information at multiple levels of cellular function and physiology. One of these critical platforms is information about the metabolome—the set of end products of cellular processes that underpin biological systems. The detection and understanding of these metabolic end products are key to linking cellular processes to other domains of biologic data, such as genomics, transcriptomics, and proteomics. This allows researchers and clinicians to make critical connections between molecular, cellular, organ-wide, and organism-wide findings to better understand how diseases arise. Thus, this Special Issue hopes to highlight research in which plasma-based metabolomics is a prominent part of scientific discovery whether in uncovering fundamental biological pathways, in translational science, or in direct clinical care, and thereby hopes to enrich our understanding of the value and importance of this branch of biologic research.
Dr. Wasim A. Dar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabalome
- precision medicine
- molecular phenotypes
- metabolic derangements
- chemical fingerprinting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
